NSF to spend $81M to boost nano-research; Meditation app co. raises $34M+;

@FierceMedDev: ICYMI yesterday: Pentax backs $8M+ round for electrosurgery startup Creo. Article | Follow @FierceMedDev

@EmilyWFierce: Report: Cancer drug spending fuels large increases in Medicare discount drug program. ICYMI from FiercePharma | Follow @EmilyWFierce

> Meditation app maker HeadSpace has raised $34.1 million to create "a personal trainer for your mind." SEC filing

> Private equity firm Advent will buy 13% of the Brazilian medical diagnostics company Fleury. Story

> The National Science Foundation will spend $81 million over the next 5 years to support 16 sites conducting advanced nano-scale research; it will be coordinated by a new agency, the National Nanotechnology Coordinated Infrastructure (NNCI). More

Biotech News

@FierceBiotech: Aerie skyrockets on a mixed success in second PhIII glaucoma study. Article | Follow @FierceBiotech

@JohnCFierce: First on Fierce: OrbiMed sets its sights on a $950M blockbuster biotech fund. News | Follow @JohnCFierce

> A player in J&J's hep C cocktail helps hustle a quick cure. Story

> FDA: Those worries about Addyi and alcohol? We can handle it. More

> Lehmann leaves GSK to head up immuno-oncology at Celyad. Article

Pharma News

@FiercePharma: ViroVet spins out of Aratana with focus on livestock health. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: BMS' Opdivo guns for kidney cancer nod with FDA 'breakthrough' tag. Article | Follow @CarlyHFierce

> BMJ: New analysis shows increased suicide rates in teens taking GSK's Paxil. More

> Celgene's Abraxane takes another hit from cost-effectiveness gatekeepers. Story

> Newly vocal union targets Big Pharma's payments to AHA and its leaders. Article

Vaccines News

> Takeda joins consortium that accelerates R&D for malaria, TB vaccines. Item

> Vaxent and PREVENT kick off Strep A vaccine trials. More

> Emory team to look at GSK vax response as part of NIH research. Report

> FDA panel recommends Fluad, possibly the first U.S. boosted flu jab. Story

> J&J's Janssen strikes four-year, $28.5M government partnership to advance Ebola vaccine. Article

CRO News

> PRA adding 150 jobs amid Pennsylvania expansion push. Report

> Chiltern closes its Theorem buy, doubling its workforce. Item

> Accelovance inks a nonprofit partnership for melanoma trials. Article

> WuXi brings its genomic heft to Chinese patients with hospital pact. Story

> Evotec upsizes its 2015 projections after a string of partnering deals. Article

Pharma Manufacturing News

> Pfizer Chinese JV partner Zhejiang Hisun Pharma gets FDA warning letter. More

> Nexvet picks up biologics plant in Ireland. Item

> FDA castigates Indian drugmaker over mess at API plant. Report

> Hamburg's pick in line to take over as FDA commissioner. Story

> FDA sears maker of GolfersSkin Sunscreen in warning letter. Article

Pharma Asia News

> Taiwan's TWi Pharmaceuticals raises $87M via GDR in weak pricing. Report

> China's Yabao Pharmaceutical adds to a summer string of tie-ups. Item

> Dual-listed Benitec adds fourth site for hep C trials of TT-034. More

> Low-cost genomic sequencing on the slate for China with Veritas landing? Story

> India's Glenmark says breast cancer candidate GBR 1302 moving to PhI. Article

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.